CLINICAL_TRIALS
trial_result
· 2010-01-07
Clinical Trial Update: Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease [Phase 3]
Summary
Long-term safety and tolerability results from a Phase 3 trial of adalimumab in Crohn's disease are reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-01-07